Two-tailed tests were performed unless testing a direction hypothesis, in which case a one-tailed test was used
All these results highlight the underlying mechanisms of novel antidiabetic drugs in diabetic HFpEF in modulating inflammation, oxidative stress and lipotoxicity (Fig
The authors declared that there are no conflicts of interest
Participants lost 16.7% of baseline weight over 64 weeks, matching clinical trial outcomes despite using half the typical drug dose
If youre looking for more support, download Noom on iOS & Android
The rise in diet-related diseases has changed how US consumers view food, with many Americans becoming more conscious of what theyre putting in their bodies and has led to an explosive growth in usage of GLP-1 agonist drugs like Ozempic, Wegovy and Mounjaro, with projections putting the number of users between 10 to 70 million by 2028